Advertisement
Advertisement

ANEB

ANEB logo

Anebulo Pharmaceuticals, Inc. Common Stock

1.02
USD
-0.02
-1.92%
Apr 17, 15:59 UTC -4
Closed
exchange

After-Market

1.02

0.00
0.00%

Anebulo Pharmaceuticals, Inc. Common Stock Profile

About

Anebulo Pharmaceuticals Inc. is a clinical-stage biotechnology company. It involved in developing novel solutions for people suffering from cannabinoid overdose and substance addiction. The company's product candidate includes ANEB-001. Anebulo Pharmaceuticals Inc. is based in Texas, United States.

Info & Links

CEO

Richard Anthony Cunningham

Headquarters

1017 Ranch Road 620 South, SUITE 107
LAKEWAY, TX 78734, UNITED STATES

Sector

Medical

Auditor

EisnerAmper LLP

Share holders

13

Employees

3

Anebulo Pharmaceuticals, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

41.91M

Enterprise Value

26.91M

Enterprise Value/EBITDA(ttm)

-3.46

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

3.89

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-119.54%

Return on Invested Capital(ttm)

-200.98%

Return on Assets(ttm)

-108.08%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-7.77M

Net Income Available to Common(ttm)

-7.67M

Diluted EPS(ttm)

-0.28

Share Statistics

Beta (5Y Monthly)

-1.15

52-Week Change

-66.00%

S&P 500 52-Week Change

6.35%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

41.08M

Dividend Yield

0.00%

Float4

3.66M

% Held by Insiders

85.90%

% Held by Institutions

28.40%

Balance Sheet

Total Cash(mrq)

15.00M

Total Cash Per Share(mrq)

0.37

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

17.52%

Quick Ratio(mrq)

3.45%

Book Value Per Share(mrq)

0.36

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.11

Free Cash Flow(ytd)

-3.10M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement